BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value: $515M (90.1% shares, 9.9% debt)

Holdings (24)

LGND LIGAND PHARMACEUTICALS INC 26.3%

Value $136M Shares 3,621,665 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 13.8%

Value $71.08M Shares 5,026,766 Est. Cost — Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 10.1%

Value $52.26M Shares 5,252,561 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 9.8%

Value $50.54M Shares 11,131,858 Est. Cost — Unrealized —

— EXELIXIS INC 7.6%

Value $39.41M Shares 40,735,000 Est. Cost — Unrealized —

— RIGEL PHARMACEUTICALS INC 6.3%

Value $32.5M Shares 9,730,697 Est. Cost — Unrealized —

— TARGACEPT INC 5.1%

Value $26.35M Shares 6,171,669 Est. Cost — Unrealized —

— CYTOKINETICS INC 3.9%

Value $19.89M Shares 1,718,905 Est. Cost — Unrealized —

— ONCOTHYREON INC 2.5%

Value $12.63M Shares 8,093,278 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 2.2%

Value $11.42M Shares 12,000,000 Est. Cost — Unrealized —

EXEL EXELIXIS INC 2.2%

Value $11.36M Shares 2,502,256 Est. Cost — Unrealized —

— QLT INC 2.0%

Value $10.4M Shares 2,370,263 Est. Cost — Unrealized —

— PORTOLA PHARMACEUTICALS INC 1.5%

Value $7.513M Shares 305,786 Est. Cost — Unrealized —

— RECEPTOS INC 1.2%

Value $6.365M Shares 320,000 Est. Cost — Unrealized —

— ARQULE INC 1.2%

Value $6.107M Shares 2,632,432 Est. Cost — Unrealized —

— PAIN THERAPEUTICS INC 1.0%

Value $5.21M Shares 2,357,327 Est. Cost — Unrealized —

— AVANIR PHARMACEUTICALS INC 0.9%

Value $4.628M Shares 1,006,053 Est. Cost — Unrealized —

— PALATIN TECHNOLOGIES INC 0.6%

Value $3.12M Shares 5,200,000 Est. Cost — Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 0.5%

Value $2.718M Shares 153,500 Est. Cost — Unrealized —

— REGULUS THERAPEUTICS INC 0.5%

Value $2.614M Shares 266,445 Est. Cost — Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.4%

Value $2.073M Shares 4,477,000 Est. Cost — Unrealized —

— FLAMEL TECHNOLOGIES SA 0.2%

Value $931K Shares 151,406 Est. Cost — Unrealized —

— TRANSCEPT PHARMACEUTICALS INC 0.1%

Value $453K Shares 150,000 Est. Cost — Unrealized —

— GENVEC INC 0.0%

Value $180K Shares 486,100 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS INC	3,621,665	$136M	26.3%	—	—	COM NEW	53220K504
—	CHEMOCENTRYX INC	5,026,766	$71.08M	13.8%	—	—	COM	16383L106
IRWD	IRONWOOD PHARMACEUTICALS INC	5,252,561	$52.26M	10.1%	—	—	COM CL A	46333X108
—	ARRAY BIOPHARMA INC	11,131,858	$50.54M	9.8%	—	—	COM	04269X105
—	EXELIXIS INC	40,735,000	$39.41M	7.6%	—	—	NOTE 4.250% 08/15/2019	30161QAC8
—	RIGEL PHARMACEUTICALS INC	9,730,697	$32.5M	6.3%	—	—	COM NEW	766559603
—	TARGACEPT INC	6,171,669	$26.35M	5.1%	—	—	COM	87611R306
—	CYTOKINETICS INC	1,718,905	$19.89M	3.9%	—	—	COM	23282W100
—	ONCOTHYREON INC	8,093,278	$12.63M	2.5%	—	—	COM	682324108
—	ARRAY BIOPHARMA INC	12,000,000	$11.42M	2.2%	—	—	NOTE 3.000% 06/01/2020	04269XAA3
EXEL	EXELIXIS INC	2,502,256	$11.36M	2.2%	—	—	COM	30161Q104
—	QLT INC	2,370,263	$10.4M	2.0%	—	—	COM	746927102
—	PORTOLA PHARMACEUTICALS INC	305,786	$7.513M	1.5%	—	—	COM	737010108
—	RECEPTOS INC	320,000	$6.365M	1.2%	—	—	COM	756207106
—	ARQULE INC	2,632,432	$6.107M	1.2%	—	—	COM	04269E107
—	PAIN THERAPEUTICS INC	2,357,327	$5.21M	1.0%	—	—	COM	69562K100
—	AVANIR PHARMACEUTICALS INC	1,006,053	$4.628M	0.9%	—	—	CL A NEW	05348P401
—	PALATIN TECHNOLOGIES INC	5,200,000	$3.12M	0.6%	—	—	COM PAR $ .01	696077403
ENTA	ENANTA PHARMACEUTICALS INC	153,500	$2.718M	0.5%	—	—	COM	29251M106
—	REGULUS THERAPEUTICS INC	266,445	$2.614M	0.5%	—	—	COM	75915K101
—	ANTHERA PHARMACEUTICALS INC	4,477,000	$2.073M	0.4%	—	—	COM	03674U102
—	FLAMEL TECHNOLOGIES SA	151,406	$931K	0.2%	—	—	SPONSORED ADR	338488109
—	TRANSCEPT PHARMACEUTICALS INC	150,000	$453K	0.1%	—	—	COM	89354M106
—	GENVEC INC	486,100	$180K	0.0%	—	—	COM NEW	37246C307